The underlying mechanism of URGCP-induced NF-κB pathway activity in glioma cells still unclear, while, some reports indicate that URGCP increases the levels of phosphorylated IKKs in hepatocellular carcinoma cells and non-small cell lung cancer cells8,10. This evidence concerns the gene NFKB1 and glioma.